Historical salary details - Dr. Christopher Gibson, PhD, Chief Executive Officer, Director and President, Recursion Pharmaceuticals Inc - Ordinary Shares - Class A
Dr. Christopher Gibson, PhD has been the Chief Executive Officer, Director and President of Recursion Pharmaceuticals Inc - Ordinary Shares - Class A since 04 Mar 2013. View his historical salary.
Dr. Christopher Gibson, Phd
Chief Executive Officer, Director and President
-
Gross Remuneration
-
Current Company
Recursion Pharmaceuticals Inc - Ordinary Shares - Class A
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Recursion Pharmaceuticals Inc - Ordinary Shares - Class A | Chief Executive Officer, Director and President | - | - |
| 2023 | Recursion Pharmaceuticals Inc - Ordinary Shares - Class A | Chief Executive Officer and Director | 8.6 M | 36.4 % |
| 2023 | Recursion Pharmaceuticals Inc - Ordinary Shares - Class A | Chief Executive Officer and Director | - | - |
| 2022 | Recursion Pharmaceuticals Inc - Ordinary Shares - Class A | Chief Executive Officer and Director | 6.3 M | 837.6 % |
| 2021 | Recursion Pharmaceuticals Inc - Ordinary Shares - Class A | - | 673.6 K | -73.9 % |
| 2021 | Recursion Pharmaceuticals Inc - Ordinary Shares - Class A | Chief Executive Officer and Director | 673.6 K | -73.9 % |
| 2020 | Recursion Pharmaceuticals Inc - Ordinary Shares - Class A | - | 2.6 M | - |
| 2020 | Recursion Pharmaceuticals Inc - Ordinary Shares - Class A | - | 2.6 M | - |
| 2020 | Recursion Pharmaceuticals Inc - Ordinary Shares - Class A | Chief Executive Officer and Director | 2.6 M | - |